Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ryanodine Receptor Calcium Release Channel | 41 | 2026 | 91 | 3.540 |
Why?
|
| Calcium | 42 | 2026 | 244 | 3.220 |
Why?
|
| Calcium Channels | 27 | 2013 | 80 | 1.910 |
Why?
|
| Sarcoplasmic Reticulum | 30 | 2026 | 131 | 1.360 |
Why?
|
| Calcium Signaling | 13 | 2026 | 80 | 1.190 |
Why?
|
| Myocardium | 15 | 2016 | 63 | 1.190 |
Why?
|
| Animals | 55 | 2026 | 1349 | 1.070 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2024 | 31 | 1.000 |
Why?
|
| Ion Channel Gating | 16 | 2017 | 68 | 0.930 |
Why?
|
| Muscle, Skeletal | 6 | 2026 | 112 | 0.690 |
Why?
|
| Muscle Proteins | 9 | 1997 | 19 | 0.650 |
Why?
|
| Myocytes, Cardiac | 6 | 2024 | 44 | 0.620 |
Why?
|
| Muscles | 11 | 1994 | 40 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 3 | 2024 | 3 | 0.490 |
Why?
|
| Peptides | 1 | 2016 | 22 | 0.470 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 66 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 7 | 2000 | 11 | 0.410 |
Why?
|
| Heart | 7 | 2016 | 24 | 0.400 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 8 | 2024 | 11 | 0.320 |
Why?
|
| Mutation, Missense | 3 | 2024 | 10 | 0.310 |
Why?
|
| Receptors, Cholinergic | 7 | 1993 | 10 | 0.300 |
Why?
|
| Mice | 9 | 2026 | 465 | 0.300 |
Why?
|
| Humans | 15 | 2025 | 5837 | 0.280 |
Why?
|
| Calmodulin | 2 | 2019 | 5 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2018 | 10 | 0.270 |
Why?
|
| Age Factors | 3 | 2025 | 181 | 0.260 |
Why?
|
| Muscle Contraction | 6 | 2000 | 44 | 0.260 |
Why?
|
| Magnesium | 4 | 2016 | 24 | 0.260 |
Why?
|
| Lipid Bilayers | 13 | 2016 | 31 | 0.260 |
Why?
|
| Models, Biological | 6 | 2018 | 132 | 0.250 |
Why?
|
| Adaptation, Physiological | 4 | 2002 | 21 | 0.240 |
Why?
|
| In Vitro Techniques | 12 | 2003 | 86 | 0.240 |
Why?
|
| Doxorubicin | 1 | 2026 | 14 | 0.240 |
Why?
|
| Muscular Diseases | 1 | 2026 | 9 | 0.240 |
Why?
|
| Oxidative Stress | 1 | 2026 | 25 | 0.240 |
Why?
|
| Membrane Potentials | 13 | 2016 | 106 | 0.240 |
Why?
|
| Caffeine | 8 | 2003 | 31 | 0.230 |
Why?
|
| Mutation | 3 | 2021 | 101 | 0.220 |
Why?
|
| Blood Glucose | 1 | 2025 | 30 | 0.220 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 2 | 0.220 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2024 | 1 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2024 | 3 | 0.220 |
Why?
|
| Dogs | 10 | 2002 | 75 | 0.210 |
Why?
|
| Male | 10 | 2026 | 3399 | 0.200 |
Why?
|
| Cytoplasm | 2 | 2003 | 15 | 0.200 |
Why?
|
| Tachycardia, Ventricular | 2 | 2021 | 8 | 0.200 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 1 | 0.190 |
Why?
|
| Heart Atria | 2 | 2024 | 6 | 0.190 |
Why?
|
| Kinetics | 14 | 2002 | 75 | 0.190 |
Why?
|
| Malignant Hyperthermia | 3 | 1993 | 16 | 0.180 |
Why?
|
| Atrial Fibrillation | 2 | 2024 | 23 | 0.180 |
Why?
|
| Ryanodine | 9 | 2002 | 14 | 0.180 |
Why?
|
| Potassium | 2 | 2016 | 15 | 0.180 |
Why?
|
| Ethylenediamines | 3 | 1997 | 3 | 0.170 |
Why?
|
| Acetates | 3 | 1997 | 4 | 0.170 |
Why?
|
| Rabbits | 11 | 2018 | 78 | 0.170 |
Why?
|
| Rats | 9 | 2013 | 282 | 0.160 |
Why?
|
| Heart Rate | 2 | 2016 | 25 | 0.160 |
Why?
|
| Calcium Channel Blockers | 4 | 2007 | 17 | 0.160 |
Why?
|
| Heart Ventricles | 5 | 2007 | 29 | 0.150 |
Why?
|
| Microsomes | 7 | 2000 | 9 | 0.140 |
Why?
|
| Calcium Channels, L-Type | 4 | 2019 | 34 | 0.140 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 5 | 2000 | 8 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2018 | 167 | 0.140 |
Why?
|
| Chelating Agents | 2 | 1997 | 6 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2019 | 11 | 0.130 |
Why?
|
| Chlorides | 2 | 2016 | 10 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 4 | 2003 | 57 | 0.130 |
Why?
|
| Algorithms | 4 | 2016 | 82 | 0.120 |
Why?
|
| Nebivolol | 1 | 2016 | 1 | 0.120 |
Why?
|
| Myocardial Contraction | 3 | 2016 | 24 | 0.120 |
Why?
|
| Action Potentials | 4 | 2026 | 47 | 0.120 |
Why?
|
| Scorpion Venoms | 1 | 2016 | 2 | 0.120 |
Why?
|
| Photolysis | 4 | 1997 | 5 | 0.120 |
Why?
|
| Cesium | 4 | 1999 | 5 | 0.110 |
Why?
|
| Female | 6 | 2025 | 3346 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2026 | 8 | 0.100 |
Why?
|
| Cell Line | 4 | 2018 | 72 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2019 | 13 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 222 | 0.100 |
Why?
|
| Cocaine | 1 | 2013 | 16 | 0.100 |
Why?
|
| Calsequestrin | 1 | 2013 | 27 | 0.100 |
Why?
|
| Swine | 4 | 2003 | 24 | 0.100 |
Why?
|
| Ligands | 5 | 2004 | 13 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2026 | 122 | 0.090 |
Why?
|
| Adenosine Triphosphate | 5 | 2002 | 12 | 0.090 |
Why?
|
| Rana pipiens | 3 | 2003 | 47 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 53 | 0.090 |
Why?
|
| Antibodies | 1 | 1991 | 17 | 0.080 |
Why?
|
| Binding Sites | 3 | 2019 | 24 | 0.080 |
Why?
|
| Permeability | 3 | 1999 | 17 | 0.080 |
Why?
|
| Sodium Compounds | 1 | 1990 | 4 | 0.080 |
Why?
|
| Perchlorates | 1 | 1990 | 5 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 4 | 0.080 |
Why?
|
| Ion Channels | 6 | 1999 | 74 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2000 | 46 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2000 | 51 | 0.070 |
Why?
|
| Recombinant Proteins | 5 | 2000 | 64 | 0.070 |
Why?
|
| Protein Binding | 3 | 2019 | 43 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1999 | 4 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2025 | 37 | 0.060 |
Why?
|
| Adult | 2 | 2025 | 1670 | 0.060 |
Why?
|
| Signal Transduction | 2 | 1998 | 139 | 0.060 |
Why?
|
| Barium | 2 | 1999 | 7 | 0.060 |
Why?
|
| Electrophysiology | 3 | 1999 | 58 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2026 | 4 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 36 | 0.060 |
Why?
|
| Cytosol | 2 | 2017 | 25 | 0.060 |
Why?
|
| Potassium Channels | 3 | 2018 | 16 | 0.060 |
Why?
|
| Arsenazo III | 1 | 1986 | 1 | 0.060 |
Why?
|
| Azo Compounds | 1 | 1986 | 2 | 0.060 |
Why?
|
| COS Cells | 3 | 2000 | 9 | 0.060 |
Why?
|
| Protein Conformation | 5 | 2013 | 25 | 0.060 |
Why?
|
| Fasting | 1 | 2025 | 6 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2025 | 10 | 0.060 |
Why?
|
| Biopsy | 1 | 2025 | 37 | 0.060 |
Why?
|
| Purkinje Cells | 1 | 2024 | 3 | 0.050 |
Why?
|
| Ions | 3 | 2016 | 26 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 129 | 0.050 |
Why?
|
| Benzodioxoles | 1 | 2024 | 1 | 0.050 |
Why?
|
| Benzamides | 1 | 2024 | 3 | 0.050 |
Why?
|
| Strontium | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2004 | 2 | 0.050 |
Why?
|
| Ethanol | 1 | 2024 | 17 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 123 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2003 | 6 | 0.050 |
Why?
|
| Feedback | 1 | 2002 | 11 | 0.050 |
Why?
|
| Reference Values | 3 | 1993 | 45 | 0.050 |
Why?
|
| Intracellular Membranes | 4 | 1998 | 9 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2018 | 48 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 1993 | 8 | 0.040 |
Why?
|
| Electric Conductivity | 4 | 1996 | 48 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 4 | 0.040 |
Why?
|
| Daunorubicin | 1 | 2000 | 1 | 0.040 |
Why?
|
| Reaction Time | 1 | 2000 | 39 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 13 | 0.040 |
Why?
|
| Cerebellum | 2 | 1998 | 8 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 2000 | 6 | 0.040 |
Why?
|
| Receptors, Nicotinic | 2 | 1990 | 3 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 1 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 17 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 17 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 189 | 0.040 |
Why?
|
| Diffusion | 1 | 1999 | 11 | 0.040 |
Why?
|
| Biophysical Phenomena | 2 | 1998 | 16 | 0.040 |
Why?
|
| Biophysics | 2 | 1998 | 21 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1998 | 1 | 0.040 |
Why?
|
| Calcium Channel Agonists | 1 | 1998 | 1 | 0.040 |
Why?
|
| Apoptosis | 1 | 1999 | 65 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 1998 | 1 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 1998 | 2 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 1998 | 6 | 0.040 |
Why?
|
| Electrochemistry | 2 | 1997 | 17 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 1998 | 21 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 1997 | 9 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 4 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 6 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2018 | 4 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 21 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 24 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1997 | 46 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 36 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 6 | 0.030 |
Why?
|
| Diastole | 1 | 2018 | 16 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2013 | 24 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2007 | 43 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 94 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 4 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 7 | 0.030 |
Why?
|
| Diazonium Compounds | 1 | 1997 | 1 | 0.030 |
Why?
|
| Phenoxyacetates | 1 | 1997 | 1 | 0.030 |
Why?
|
| Phospholipids | 1 | 1997 | 4 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 2 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 1 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 5 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 4 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carbazoles | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 7 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Propanolamines | 1 | 2016 | 2 | 0.030 |
Why?
|
| Putrescine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Spermidine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Spermine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2016 | 14 | 0.030 |
Why?
|
| Endoplasmic Reticulum, Smooth | 1 | 1996 | 1 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 11 | 0.030 |
Why?
|
| Transfection | 3 | 2000 | 31 | 0.030 |
Why?
|
| Time Factors | 3 | 2004 | 374 | 0.030 |
Why?
|
| Aging | 1 | 2018 | 352 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1994 | 2 | 0.030 |
Why?
|
| Surface Properties | 1 | 1994 | 35 | 0.030 |
Why?
|
| Chloride Channels | 2 | 1991 | 4 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 1991 | 38 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 1 | 0.020 |
Why?
|
| Dialysis | 1 | 2013 | 2 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 7 | 0.020 |
Why?
|
| Calorimetry | 1 | 2013 | 4 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2013 | 10 | 0.020 |
Why?
|
| Light | 1 | 2013 | 23 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 1775 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 1860 | 0.020 |
Why?
|
| Models, Chemical | 2 | 1997 | 24 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 16 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1991 | 4 | 0.020 |
Why?
|
| Epitopes | 1 | 1991 | 9 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1990 | 2 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1990 | 2 | 0.020 |
Why?
|
| Alkaloids | 1 | 1989 | 3 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1989 | 3 | 0.020 |
Why?
|
| Nitrendipine | 1 | 1989 | 2 | 0.020 |
Why?
|
| Gallopamil | 1 | 1989 | 6 | 0.020 |
Why?
|
| Temperature | 1 | 1989 | 17 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1988 | 2 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2000 | 19 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 18 | 0.020 |
Why?
|
| Ferrets | 2 | 1998 | 3 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 36 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 1999 | 4 | 0.020 |
Why?
|
| Membranes | 2 | 2002 | 7 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 10 | 0.020 |
Why?
|
| Absorption | 1 | 1986 | 2 | 0.010 |
Why?
|
| Rana temporaria | 1 | 1986 | 5 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1986 | 9 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1986 | 15 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 7 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 20 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 15 | 0.010 |
Why?
|
| Biotransformation | 1 | 2002 | 3 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 18 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 51 | 0.010 |
Why?
|
| Tritium | 2 | 1993 | 2 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 125 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 163 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 2000 | 1 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2000 | 2 | 0.010 |
Why?
|
| Proteolipids | 1 | 2000 | 2 | 0.010 |
Why?
|
| Dihydropyridines | 2 | 1991 | 5 | 0.010 |
Why?
|
| Anura | 1 | 2000 | 14 | 0.010 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2000 | 6 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 29 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 29 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2000 | 27 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 3 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1999 | 3 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 5 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 31 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1998 | 3 | 0.010 |
Why?
|
| Sarcolemma | 1 | 1998 | 3 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 14 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 15 | 0.010 |
Why?
|
| Heparin | 1 | 1998 | 4 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 24 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 3 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 8 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1997 | 1 | 0.010 |
Why?
|
| Buffers | 1 | 1997 | 5 | 0.010 |
Why?
|
| Fluorescence | 1 | 1997 | 4 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 1997 | 7 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 26 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 23 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 87 | 0.010 |
Why?
|
| Cations | 1 | 1997 | 4 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1997 | 7 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1997 | 21 | 0.010 |
Why?
|
| Chickens | 1 | 1996 | 10 | 0.010 |
Why?
|
| Mammals | 1 | 1996 | 8 | 0.010 |
Why?
|
| Isomerism | 1 | 1993 | 1 | 0.010 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1993 | 2 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 4 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1993 | 12 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1993 | 21 | 0.010 |
Why?
|
| Isradipine | 1 | 1989 | 2 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1989 | 2 | 0.000 |
Why?
|
| Alcohols | 1 | 1988 | 2 | 0.000 |
Why?
|
| Tromethamine | 1 | 1988 | 1 | 0.000 |
Why?
|
| Ruthenium Red | 1 | 1988 | 6 | 0.000 |
Why?
|
| Solutions | 1 | 1988 | 8 | 0.000 |
Why?
|